Improving Patient Safety: An Imperative in Medical Genetics and Genomics (Version 2024)
(1)
Image For Activity Cover
Availability
On-Demand
Expires on 12/04/2025
Cost
$0.00
Credit Offered
3 CME (AMA) Credits
3 CME (Other) Credits
3 Certificate of Participation Credits
3 CCP-PART II Credits

Improving Patient Safety: An Imperative in Medical Genetics and Genomics Healthcare (2024 Version)

Revisions:

  • November 2021: Revised by the American College of Medical Genomics Education & CME Committee.
  • November 2024: Reviewed and revised by the American College of Medical Genomics Continuing Certification Program (CCP) Committee.

This program was adopted from materials supplied by the American College of Obstetricians and Gynecologists and modified by the American Board of Medical Genetics and Genomics

 

Date of Release:                                   December 4, 2024

Expiration Date:                                    December 4, 2025

Credits offered:                                    AMA PRA Category 1TM, CME Other, Lifelong Learning and Self-Assessment (CCP Part II)

Estimate time of completion:            3.0 hours

Course must be completed by the expiration date

Course Description:
This course is comprised of an in-depth dialog of key critical topics identified as impacting patient healthcare safety. In this activity, a participant will discover the burden of medical errors on the patient and healthcare system, contributing factors for medical errors, myths regarding patient safety, pathways to reducing errors, communication techniques to improve patient safety, the importance of teamwork in the safety of the patient, identifying adverse events and how to disclose adverse events. Cases cover instructive yet challenging situations relevant to both clinical genetics and laboratory genetics and genomics. This activity allows the participants to assess their comprehension and application of the material presented in the module.

 

Target Audience

Clinical geneticists and clinical laboratory specialists

 

Learning Objectives

At the conclusion of this course, participants should be able to:

  • Elaborate on the burden of medical errors
  • List the key factors contributing to medical errors
  • Describe key paths to error reduction
  • Identify ways in which communication can reduce medical errors
  • Elaborate on the critical impact of teamwork on patient safety
  • Describe the key steps in reporting and disclosing adverse events

 

Topics                                                                                               Slide #s

  • Burden of Medical Errors                                                     9-14
  • Medical Errors: Contributing Factors                                 15-25
  • Patient Safety Myths                                                             26-31
  • Paths to Error Reduction                                                      32-43
  • Quality Improvement & Patient Safety                              44-48
  • Communication and Patient Safety                                    49-64
  • Enhancing Patient Safety through Teamwork                   65-78
  • Disclosure of Adverse Events                                               79-92
  • Protecting Patients in Clinical Genetics: Examples           93-97
  • Summary: Improving Patient Safety                                   98-99


Authors:

Yang Cao, PhD, FACMG

Washington University in Saint Louis


Seyma Eroglu, MD

National Human Genome Research Institute (NHGRI)

Kristina P. Cusmano-Ozog, MD, FACMG

Stanford Medical School


Jinbo Fan, PhD, FACMG

University of Virginia

 

Ryan Gates, MD, FACMG

Cook Children's Hospital

 

Ayuko Iverson, MD, FACMG

Icahn School of Medicine at Mount Sinai

 

Staci Kallish, DO, FACMG

University of Pennsylvania

 

Erin T. Strovel, PhD, FACMG

University of Maryland

 

Gopalrao V. Velagaleti, PhD, FACMG

University of Texas Health Sciences Center at San Antonio

 

 


AMA PRA Category 1 CreditTM, CME Other, and Lifelong Learning and Self-Assessment (CCP Part II)

 

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Credit Designation

The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

 

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

 

Technical Support:
You can reach us by email at
education@acmg.net or call 301-718-9603.
Support Center Hours: Monday – Friday, 9:00 AM – 5:00 PM Eastern Time.


Claiming your Educational Credits

This activity consists of:

    1. View the PPT content.
    2. Take the post-test, the test may be taken as often as necessary to achieve a passing score of 80% or better is required to receive credit. If you do not
    achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again.

    3. Complete the Overal Evaluation Form. 


Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

 

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

 

All of the relevant financial relationships listed for these individuals have been mitigated.

 

Name

Role

Relationship / Company

Cao, Yang

Committee Member

No Relevant Financial Relationships

Eroglu, Seyma

Committee Member

No Relevant Financial Relationships

Fan, Jinbo

Committee Member

No Relevant Financial Relationships

Gates, Ryan

Committee Member

No Relevant Financial Relationships

Iverson, Ayuko

Committee Member / Peer Reviewer

No Relevant Financial Relationships

Kallish, Staci

Committee Member

Consultant: Amicus Therapeutics, Inc., Sanofi Pasteur Inc.
Research: Idorsia Pharmaceuticals US Inc, Incyte, Ipsen Pharma, Sanofi Pasteur Inc.

Kusmano-Ozog, Kristina

Committee Member

No Relevant Financial Relationships

Strovel, Erin

Committee Member

No Relevant Financial Relationships

Velagaleti, Gopal

Committee Member / Peer Reviewer

No Relevant Financial Relationships

Radford, Jane

Committee Member

No Relevant Financial Relationships

Whelan, Colleen

Committee Member

No Relevant Financial Relationships

 

© 2025 American College of Medical Genetics and Genomics. All rights reserved.

Powered By